Picture of Cansino Biologics logo

6185 Cansino Biologics News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Cansino Biologics Posts QTRLY Operating Revenue Of RMB137.2 Million

April 29 (Reuters) - CanSino Biologics Inc 688185.SS:

QTRLY OPERATING REVENUE RMB137.2 MILLION

QTRLY NET LOSS ATTRIBUTABLE RMB11.5 MILLION

Further company coverage: 688185.SS

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cansino Biologics

See all news